• G-Quadruplex Modulation of TDP-43: Insights for Neurodegener

  2026-05-18

  Oldani et al. reveal that RNA G-quadruplexes (G4s) modulate TDP-43 protein condensation, distribution, and cytotoxicity across cell models. Their findings connect G4 stabilization to reduced TDP-43 toxicity, providing mechanistic insight for therapeutic exploration in ALS and related neurodegenerative diseases.

• FLAG tag Peptide: Precision in Recombinant Protein Detection

  2026-05-18

  The FLAG tag Peptide (DYKDDDDK) empowers researchers with high-purity, gentle elution and robust specificity for recombinant protein workflows. This article unpacks practical protocols, comparative advantages, and troubleshooting strategies, drawing on recent structural evidence and benchmarked lab experiences.

• Filipin III: Precision Cholesterol Detection in Membranes

  2026-05-17

  Filipin III stands as the gold-standard polyene macrolide antibiotic for robust, quantitative visualization of cholesterol-rich membrane microdomains. This guide delivers stepwise protocols, advanced troubleshooting, and practical insights—translating breakthrough findings in immunometabolism into actionable membrane research workflows.

• A-1210477: MCL-1 Inhibitor Workflows for Cancer Cell Apoptos

  2026-05-16

  A-1210477 enables precise interrogation of MCL-1-dependent apoptosis with superior selectivity, empowering advanced mitochondrial apoptosis assays in cancer research. This article delivers practical workflow enhancements, troubleshooting strategies, and critical insights for maximizing reproducibility and biological relevance with this BH3 mimetic.

• Bazedoxifene: Selective Estrogen Receptor Modulator for Rese

  2026-05-15

  Bazedoxifene stands out as a third-generation selective estrogen receptor modulator optimized for nuanced control of estrogen signaling in bone, cancer, and metabolic studies. Its dual utility in osteoporosis and IL-6/GP130-related cancer pathways unlocks robust, reproducible workflows for advanced bench science.

• Angiotensin (1-7): Applied Workflows and Experimental Optimi

  2026-05-15

  Angiotensin (1-7) unlocks powerful anti-fibrotic and anti-inflammatory research avenues, offering precise PI3K/AKT and ERK pathway modulation. This guide details advanced workflows, troubleshooting strategies, and practical assay enhancements for translational scientists using APExBIO's high-purity peptide.

• Berbamine Hydrochloride: Applied NF-κB Activity Inhibitor Pr

  2026-05-14

  Berbamine hydrochloride, a potent NF-κB activity inhibitor, unlocks advanced experimental approaches for dissecting tumorigenic pathways and ferroptosis resistance in cancer research. Discover hands-on protocols, troubleshooting insights, and the translational impact of recent mechanistic breakthroughs in hepatocellular carcinoma and leukemia models.

• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-05-14

  Harper et al. (2025) reveal that inhibition of RNA polymerase II induces cell death via an active signaling pathway, independent of global transcriptional shutdown. Their mechanistic dissection identifies the loss of hypophosphorylated RNA Pol IIA, not mRNA decay, as the apoptotic trigger—offering new context for studies of regulated cell death and informing experimental design in apoptosis research.

• HyperPFU™ high-fidelity DNA polymerase: Practical PCR Guidan

  2026-05-13

  HyperPFU™ high-fidelity DNA polymerase is engineered for precise PCR amplification of long, GC-rich, or otherwise difficult DNA targets, where standard enzymes are prone to errors or amplification failure. It is best used for applications demanding blunt-ended, high-fidelity products and is not suitable for workflows that rely on 3'-A overhangs or sticky-end generation.

• Epalrestat: Pathway Disruption for Translational Metabolic R

  2026-05-13

  This article explores the mechanistic and strategic potential of Epalrestat, a high-purity aldose reductase inhibitor from APExBIO, to disrupt the polyol pathway in models of diabetic neuropathy, neurodegeneration, and—emergingly—cancer metabolism. It offers evidence-based guidance for translational researchers targeting oxidative stress and fructose-driven malignancy, integrates pivotal findings from recent literature, and provides actionable protocol parameters. The discussion bridges metabolic, neurological, and oncological domains, highlighting how this approach outpaces traditional product overviews with forward-thinking, scenario-driven recommendations.

• hiPSC-Derived Intestinal Organoids for CYP2C19 Substrate Met

  2026-05-12

  This study presents a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids, advancing in vitro models for pharmacokinetic analysis. The resulting organoids exhibit mature epithelial differentiation and functional cytochrome P450 activities, providing a robust platform for evaluating CYP2C19 substrate metabolism in drug discovery.

• Degarelix Acetate: Workflow Optimization for Prostate Cancer

  2026-05-12

  Degarelix acetate, a potent GnRH receptor antagonist from APExBIO, empowers precise in vitro and in vivo hormone pathway interrogation. This guide translates cutting-edge aggregation science and validated workflows into clear, actionable protocols for hormone suppression and cancer research.

• Trelagliptin Enhances Osteoblastic Differentiation via RUNX2

  2026-05-11

  This article examines a recent study demonstrating that trelagliptin, a DPP-4 inhibitor, stimulates osteoblastic differentiation in MC3T3-E1 cells by increasing RUNX2 expression through an AMPK-dependent pathway. These findings suggest new therapeutic potential for osteoporosis and outline key workflow considerations for blood sample preparation in related research.

• Practical Guide: Calpain Inhibitor I, ALLN for Apoptosis & I

  2026-05-11

  Calpain Inhibitor I, ALLN (SKU A2602) offers targeted inhibition of calpain and cathepsin proteases, supporting standardized workflows in apoptosis and ischemia-reperfusion injury research. It is best suited for cell-based and in vivo models requiring potent, selective protease inhibition. Use is not recommended for diagnostic or medical applications.

• Nigericin Sodium Salt: Technical Guide for Ion Transport Stu

  2026-05-10

  Nigericin sodium salt enables researchers to manipulate potassium and hydrogen ion gradients across biological membranes, making it a key tool for investigating ion transport, cytoplasmic pH regulation, and platelet aggregation modulation. Its use is best suited to controlled in vitro workflows; it is not appropriate for diagnostic or clinical applications, and careful handling is essential due to solubility and stability characteristics.

614 records 7/41 page Previous Next First page 上5页 678910 下5页 Last page